By Kelly Cloonan
Shares of Phathom Pharmaceuticals fell after the company said Chief Executive Officer Terrie Curran has resigned and will be succeeded by SaNOtize's Steven Basta.
The stock declined 22% to $4.88 on Tuesday, bringing its fall over the last 12 months to 54%.
Phathom said Curran has resigned from her roles as president, CEO and a member of the board for personal reasons.
Basta joins the Florham Park, N.J., biopharmaceutical company as president, CEO and a director, the company said.
Basta previously led SaNOtize, an anti-infective therapies company.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
April 01, 2025 15:24 ET (19:24 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。